Cargando…
TRAAP2 - TRAnexamic Acid for Preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo- controlled trial – a study protocol
BACKGROUND: An antifibrinolytic agent that blocks lysine-binding sites on plasminogen molecules, tranexamic acid reduces bleeding-related mortality in women with postpartum hemorrhage (PPH), especially administered fairly soon after delivery. According to the randomized controlled trials thus far re...
Autores principales: | Sentilhes, Loïc, Daniel, Valérie, Deneux-Tharaux, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995226/ https://www.ncbi.nlm.nih.gov/pubmed/32005192 http://dx.doi.org/10.1186/s12884-019-2718-4 |
Ejemplares similares
-
Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial
por: Sentilhes, Loïc, et al.
Publicado: (2015) -
Tranexamic acid for the prevention of postpartum bleeding: Protocol for a systematic review and individual patient data meta-analysis
por: Ker, Katharine, et al.
Publicado: (2023) -
Undiagnosed abnormal postpartum blood loss: Incidence and risk factors
por: Girault, Aude, et al.
Publicado: (2018) -
Effect of routine controlled cord traction as part of the active management of the third stage of labour on postpartum haemorrhage: multicentre randomised controlled trial (TRACOR)
por: Deneux-Tharaux, Catherine, et al.
Publicado: (2013) -
Risk factors for chronic post-traumatic stress disorder development one year after vaginal delivery: a prospective, observational study
por: Sentilhes, Loïc, et al.
Publicado: (2017)